The efficacy of N-acetylcysteine in preventing doxorubicin-induced cardiomyopathy in dogs.
D000111:Acetylcysteine / Q000494:pharmacology*; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D006328:Cardiac Catheterization; D009202:Cardiomyopathies / Q000139:chemically induced* / Q000517:prevention & control; D004285:Dogs; D004317:Doxorubicin / Q000633:toxicity*; D004347:Drug Interactions; D004452:Echocardiography; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D013599:Systole
D000975:Antioxidants; D004317:Doxorubicin; D000111:Acetylcysteine